The Spanish GIRO Guideline: A Paradigm Shift in the Management of Obesity in Adults

Abstract

Adipose tissue; Adults; Obesity

Tejido adiposo; Adultos; Obesidad

Teixit adipós; Adults; Obesitat

Introduction: Current obesogenic environments, along with intrinsic factors, contribute to the obesity pandemic, which impacts the quality of life and healthcare for individuals with obesity. In addition, discrimination and stigma related to obesity remain widespread in our society. In this scenario, the Spanish Society for the Study of Obesity (SEEDO), in collaboration with 38 recognized scientific societies and 12 patients’ organization, has elaborated the Spanish guideline for obesity management in adults, referred to as the GIRO guideline. GIRO aims to drive a shift in obesity management and serve as a guide for healthcare professionals (HCPs) to address this chronic and multifactorial disease. Methods: A comprehensive systematic review was conducted and completed with experts’ contribution, with a particular focus on Spanish society. The quality of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. Experts selected the recommendations and determined their strength through consensus. Results: A total of 121 recommendations were proposed, including 32 adopted from the Canadian Adult Obesity Clinical Practice Guidelines and 89 specific recommendations created for the Spanish context, and were distributed across five areas of application: (1) recognition of obesity as a chronic disease, (2) obesity assessment, (3) multidisciplinary approach to obesity treatment, (4) recommendations for obesity management in special populations, and (5) implementation of the GIRO guideline and future challenges. Conclusion: The GIRO recommendations are intended to serve as a useful and interactive tool for HCPs, policymakers, and other stakeholders to ensure access to and quality of healthcare for individuals living with obesity.

The GIRO project (including the guideline elaboration and manuscript publication) has been promoted and driven by the SEEDO, through a non-conditional grant from Novo Nordisk Spain. The funder (Novo Nordisk Spain) had no role in the guideline nor the manuscript conception, planning, nor decision to publish.